{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:59:39Z","timestamp":1793293179649,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10585-015-9718-1","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T14:31:58Z","timestamp":1429540318000},"page":"441-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation"],"prefix":"10.1007","volume":"32","author":[{"given":"Carmela","family":"Ricciardelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor A.","family":"Lokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Cheruvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izza A.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda P.","family":"Ween","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen E.","family":"Pyragius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ruszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"issue":"2","key":"9718_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9718_CR2","first-page":"255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N et al (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2):255\u2013288","journal-title":"Endocr Rev"},{"issue":"2","key":"9718_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3835(95)03743-G","volume":"91","author":"MJ Gardner","year":"1995","unstructured":"Gardner MJ et al (1995) Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 91(2):229\u2013234","journal-title":"Cancer Lett"},{"issue":"1","key":"9718_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-2-23","volume":"2","author":"RS Freedman","year":"2004","unstructured":"Freedman RS et al (2004) Peritoneal inflammation\u2014a microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2(1):23","journal-title":"J Transl Med"},{"issue":"3","key":"9718_CR5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","volume":"73","author":"T Strobel","year":"1999","unstructured":"Strobel T, Cannistra SA (1999) Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 73(3):362\u2013367","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9718_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2006-948556","volume":"24","author":"C Ricciardelli","year":"2006","unstructured":"Ricciardelli C, Rodgers RJ (2006) Extracellular matrix of ovarian tumors. Semin Reprod Med 24(4):270\u2013282","journal-title":"Semin Reprod Med"},{"issue":"1","key":"9718_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1593\/neo.06658","volume":"9","author":"NA Said","year":"2007","unstructured":"Said NA et al (2007) SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk. Neoplasia 9(1):23\u201335","journal-title":"Neoplasia"},{"issue":"4","key":"9718_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000152941","volume":"29","author":"L Heyman","year":"2008","unstructured":"Heyman L et al (2008) Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro. Tumour Biol 29(4):231\u2013244","journal-title":"Tumour Biol"},{"issue":"4","key":"9718_CR9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA et al (2008) The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Investig 118(4):1367\u20131379","journal-title":"J Clin Investig"},{"issue":"7","key":"9718_CR10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ijc.25494","volume":"128","author":"MP Ween","year":"2011","unstructured":"Ween MP et al (2011) Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer 128(7):1570\u20131584","journal-title":"Int J Cancer"},{"issue":"8","key":"9718_CR11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.18632\/oncotarget.1122","volume":"4","author":"NA Lokman","year":"2013","unstructured":"Lokman NA et al (2013) Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget 4(8):1199\u20131211","journal-title":"Oncotarget"},{"issue":"7","key":"9718_CR12","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/j.1460-2075.1992.tb05301.x","volume":"11","author":"Y Lindqvist","year":"1992","unstructured":"Lindqvist Y et al (1992) Three-dimensional structure of transketolase, a thiamine diphosphate dependent enzyme, at 2.5 A resolution. EMBO J 11(7):2373\u20132379","journal-title":"EMBO J"},{"issue":"2","key":"9718_CR13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12264-009-1113-y","volume":"25","author":"J Zhao","year":"2009","unstructured":"Zhao J, Zhong CJ (2009) A review on research progress of transketolase. Neurosci Bull 25(2):94\u201399","journal-title":"Neurosci Bull"},{"issue":"2","key":"9718_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1207\/S15327914NC3602_2","volume":"36","author":"M Cascante","year":"2000","unstructured":"Cascante M et al (2000) Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation. Nutr Cancer 36(2):150\u2013154","journal-title":"Nutr Cancer"},{"issue":"25","key":"9718_CR15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM197712222972503","volume":"297","author":"JP Blass","year":"1977","unstructured":"Blass JP, Gibson GE (1977) Abnormality of a thiamine-requiring enzyme in patients with Wernicke\u2013Korsakoff syndrome. N Engl J Med 297(25):1367\u20131370","journal-title":"N Engl J Med"},{"issue":"8","key":"9718_CR16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","volume":"45","author":"GE Gibson","year":"1988","unstructured":"Gibson GE et al (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease. Arch Neurol 45(8):836\u2013840","journal-title":"Arch Neurol"},{"issue":"19","key":"9718_CR17","first-page":"4242","volume":"57","author":"LG Boros","year":"1997","unstructured":"Boros LG et al (1997) Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 57(19):4242\u20134248","journal-title":"Cancer Res"},{"issue":"5","key":"9718_CR18","first-page":"1183","volume":"60","author":"LG Boros","year":"2000","unstructured":"Boros LG et al (2000) Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60(5):1183\u20131185","journal-title":"Cancer Res"},{"issue":"6","key":"9718_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0306-9877(98)90271-7","volume":"50","author":"LG Boros","year":"1998","unstructured":"Boros LG et al (1998) Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action. Med Hypotheses 50(6):501\u2013506","journal-title":"Med Hypotheses"},{"issue":"1","key":"9718_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(99)00924-2","volume":"456","author":"B Rais","year":"1999","unstructured":"Rais B et al (1999) Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich\u2019s tumor cells through inhibition of the pentose cycle. FEBS Lett 456(1):113\u2013118","journal-title":"FEBS Lett"},{"issue":"11","key":"9718_CR21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891\u2013899","journal-title":"Nat Rev Cancer"},{"key":"9718_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-7-7","volume":"7","author":"TN Seyfried","year":"2010","unstructured":"Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutr Metab 7:7","journal-title":"Nutr Metab"},{"issue":"3191","key":"9718_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123(3191):309\u2013314","journal-title":"Science"},{"issue":"8","key":"9718_CR24","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1158\/1078-0432.CCR-04-2626","volume":"11","author":"GJ Kelloff","year":"2005","unstructured":"Kelloff GJ et al (2005) Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11(8):2785\u20132808","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9718_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.acra.2006.12.003","volume":"14","author":"GJ Kelloff","year":"2007","unstructured":"Kelloff GJ et al (2007) FDG-PET lymphoma demonstration project invitational workshop. Acad Radiol 14(3):330\u2013339","journal-title":"Acad Radiol"},{"issue":"1","key":"9718_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2008.07.039","volume":"69","author":"R Lavayssiere","year":"2009","unstructured":"Lavayssiere R, Cabee AE, Filmont JE (2009) Positron emission tomography (PET) and breast cancer in clinical practice. Eur J Radiol 69(1):50\u201358","journal-title":"Eur J Radiol"},{"key":"9718_CR27","first-page":"64","volume":"1","author":"R Wittig","year":"2008","unstructured":"Wittig R, Coy JF (2008) The role of glucose metabolism and glucose-associated signalling in cancer. Perspect Med Chem 1:64\u201382","journal-title":"Perspect Med Chem"},{"issue":"1\u20132","key":"9718_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1020333730485","volume":"29","author":"J Boren","year":"2002","unstructured":"Boren J et al (2002) Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development. Mol Biol Rep 29(1\u20132):7\u201312","journal-title":"Mol Biol Rep"},{"issue":"12","key":"9718_CR29","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/ijc.22227","volume":"119","author":"A Ramos-Montoya","year":"2006","unstructured":"Ramos-Montoya A et al (2006) Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int J Cancer 119(12):2733\u20132741","journal-title":"Int J Cancer"},{"issue":"4","key":"9718_CR30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.bjc.6602962","volume":"94","author":"S Langbein","year":"2006","unstructured":"Langbein S et al (2006) Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: warburg effect reinterpreted. Br J Cancer 94(4):578\u2013585","journal-title":"Br J Cancer"},{"issue":"3","key":"9718_CR31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/geno.1996.0124","volume":"32","author":"JF Coy","year":"1996","unstructured":"Coy JF et al (1996) Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 32(3):309\u2013316","journal-title":"Genomics"},{"issue":"41","key":"9718_CR32","doi-asserted-by":"crossref","first-page":"31559","DOI":"10.1074\/jbc.M110.149955","volume":"285","author":"L Mitschke","year":"2010","unstructured":"Mitschke L et al (2010) The crystal structure of human transketolase and new insights into its mode of action. J Biol Chem 285(41):31559\u201331570","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"9718_CR33","first-page":"257","volume":"51","author":"JF Coy","year":"2005","unstructured":"Coy JF et al (2005) Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 51(5\u20136):257\u2013273","journal-title":"Clin Lab"},{"issue":"1844","key":"9718_CR34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbapap.2014.06.003","volume":"9","author":"GA Kochetov","year":"2014","unstructured":"Kochetov GA, Solovjeva ON (2014) Structure and functioning mechanism of transketolase. Biochim Biophys Acta 9(1844):1608\u20131618","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9718_CR35","first-page":"657","volume":"16","author":"WI Staiger","year":"2006","unstructured":"Staiger WI et al (2006) Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol Rep 16(4):657\u2013661","journal-title":"Oncol Rep"},{"issue":"4","key":"9718_CR36","first-page":"841","volume":"17","author":"M Foldi","year":"2007","unstructured":"Foldi M et al (2007) Transketolase protein TKTL1 overexpression: a potential biomarker and therapeutic target in breast cancer. Oncol Rep 17(4):841\u2013845","journal-title":"Oncol Rep"},{"issue":"1","key":"9718_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2007.01.010","volume":"253","author":"S Zhang","year":"2007","unstructured":"Zhang S et al (2007) Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett 253(1):108\u2013114","journal-title":"Cancer Lett"},{"issue":"12","key":"9718_CR38","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00405-007-0394-x","volume":"264","author":"HU Volker","year":"2007","unstructured":"Volker HU et al (2007) Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur Arch Oto-Rhino-Laryngol 264(12):1431\u20131436","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"1","key":"9718_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1309\/6H9844AMMET82DBJ","volume":"130","author":"HU Volker","year":"2008","unstructured":"Volker HU et al (2008) Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Am J Clin Pathol 130(1):50\u201357","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"9718_CR40","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/ijc.23403","volume":"122","author":"S Langbein","year":"2008","unstructured":"Langbein S et al (2008) Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer 122(11):2422\u20132428","journal-title":"Int J Cancer"},{"issue":"4","key":"9718_CR41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4161\/cbt.7.4.5479","volume":"7","author":"S Zhang","year":"2008","unstructured":"Zhang S et al (2008) Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma. Cancer Biol Ther 7(4):517\u2013522","journal-title":"Cancer Biol Ther"},{"key":"9718_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1756-9966-28-43","volume":"28","author":"H Chen","year":"2009","unstructured":"Chen H et al (2009) Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J Exp Clin Cancer Res 28:43","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"9718_CR43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAT.0b013e32834c352b","volume":"43","author":"G Kayser","year":"2011","unstructured":"Kayser G et al (2011) Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 43(7):719\u2013724","journal-title":"Pathology"},{"key":"9718_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/1471-2407-13-569","volume":"13","author":"M Grimm","year":"2013","unstructured":"Grimm M et al (2013) A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer 13:569","journal-title":"BMC Cancer"},{"issue":"6","key":"9718_CR45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.oooo.2014.02.007","volume":"117","author":"M Grimm","year":"2014","unstructured":"Grimm M et al (2014) GLUT-1(+)\/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):743\u2013753","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"9718_CR46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1525-1438.2007.00799.x","volume":"17","author":"M Krockenberger","year":"2007","unstructured":"Krockenberger M et al (2007) Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer 17(1):101\u2013106","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"9718_CR47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/ijo_00000674","volume":"37","author":"A Mayer","year":"2010","unstructured":"Mayer A, Von Wallbrunn A, Vaupel P (2010) Glucose metabolism of malignant cells is not regulated by transketolase-like (TKTL)-1. Int J Oncol 37(2):265\u2013271","journal-title":"Int J Oncol"},{"key":"9718_CR48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4419-7756-4_17","volume":"701","author":"A Mayer","year":"2011","unstructured":"Mayer A, Von Wallbrunn A, Vaupel P (2011) Evidence against a major role for TKTL-1 in hypoxic and normoxic cancer cells. Adv Exp Med Biol 701:123\u2013128","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"9718_CR49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000355015","volume":"88","author":"S Bentz","year":"2013","unstructured":"Bentz S et al (2013) Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion 88(3):182\u2013192","journal-title":"Digestion"},{"issue":"40","key":"9718_CR50","doi-asserted-by":"crossref","first-page":"33436","DOI":"10.1074\/jbc.M112.384578","volume":"287","author":"C Wanka","year":"2012","unstructured":"Wanka C, Steinbach JP, Rieger J (2012) Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem 287(40):33436\u201333446","journal-title":"J Biol Chem"},{"issue":"3","key":"9718_CR51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1158\/1078-0432.CCR-09-2604","volume":"16","author":"W Sun","year":"2010","unstructured":"Sun W et al (2010) TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res 16(3):857\u2013866","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9718_CR52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1134\/S000629791203008X","volume":"77","author":"AO Maslova","year":"2012","unstructured":"Maslova AO, Meshalkina LE, Kochetov GA (2012) Computer modeling of transketolase-like protein, TKTL1, a marker of certain tumor tissues. Biochem Biokhimiia 77(3):296\u2013299","journal-title":"Biochem Biokhimiia"},{"issue":"3","key":"9718_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbadis.2012.12.004","volume":"1832","author":"LE Meshalkina","year":"2013","unstructured":"Meshalkina LE et al (2013) Is transketolase-like protein, TKTL1, transketolase? Biochim Biophys Acta 1832(3):387\u2013390","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"9718_CR54","doi-asserted-by":"crossref","first-page":"e48321","DOI":"10.1371\/journal.pone.0048321","volume":"7","author":"S Schneider","year":"2012","unstructured":"Schneider S et al (2012) A delta38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity. PLoS ONE 7(10):e48321","journal-title":"PLoS ONE"},{"issue":"9","key":"9718_CR55","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/cbt.9.9.11431","volume":"9","author":"W Yuan","year":"2010","unstructured":"Yuan W et al (2010) Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo. Cancer Biol Ther 9(9):710\u2013716","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"9718_CR56","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.24078","volume":"124","author":"X Xu","year":"2009","unstructured":"Xu X et al (2009) Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer 124(6):1330\u20131337","journal-title":"Int J Cancer"},{"issue":"20","key":"9718_CR57","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","volume":"29","author":"F Zhao","year":"2010","unstructured":"Zhao F et al (2010) Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 29(20):2962\u20132972","journal-title":"Oncogene"},{"issue":"15","key":"9718_CR58","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-09-4615","volume":"70","author":"H Liu","year":"2010","unstructured":"Liu H et al (2010) Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res 70(15):6368\u20136376","journal-title":"Cancer Res"},{"issue":"9","key":"9718_CR59","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00535-013-0895-x","volume":"49","author":"T Shimizu","year":"2014","unstructured":"Shimizu T et al (2014) Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas. J Gastroenterol 49(9):1324\u20131332","journal-title":"J Gastroenterol"},{"issue":"31","key":"9718_CR60","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/onc.2009.139","volume":"28","author":"S Mori","year":"2009","unstructured":"Mori S et al (2009) Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 28(31):2796\u20132805","journal-title":"Oncogene"},{"issue":"6","key":"9718_CR61","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1183\/09031936.00015710","volume":"37","author":"CC Lin","year":"2011","unstructured":"Lin CC et al (2011) Malignant pleural effusion cells show aberrant glucose metabolism gene expression. Eur Respir J 37(6):1453\u20131465","journal-title":"Eur Respir J"},{"issue":"6","key":"9718_CR62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.acthis.2009.05.010","volume":"112","author":"MF Mohd Omar","year":"2010","unstructured":"Mohd Omar MF et al (2010) Molecular-assisted immunohistochemical optimization. Acta Histochem 112(6):519\u2013528","journal-title":"Acta Histochem"},{"issue":"12","key":"9718_CR63","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen M et al (2010) Towards a knowledge-based human protein atlas. Nat Biotechnol 28(12):1248\u20131250","journal-title":"Nat Biotechnol"},{"issue":"1","key":"9718_CR64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1559-0275-11-13","volume":"11","author":"A Bery","year":"2014","unstructured":"Bery A et al (2014) Deciphering the ovarian cancer ascites fluid peptidome. Clin Proteomics 11(1):13","journal-title":"Clin Proteomics"},{"issue":"1","key":"9718_CR65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1097-4652(199707)172:1<63::AID-JCP7>3.0.CO;2-B","volume":"172","author":"F Paoletti","year":"1997","unstructured":"Paoletti F, Mocali A, Tombaccini D (1997) Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts. J Cell Physiol 172(1):63\u201368","journal-title":"J Cell Physiol"},{"issue":"12","key":"9718_CR66","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/ijc.24262","volume":"124","author":"P Vizan","year":"2009","unstructured":"Vizan P et al (2009) Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29. Int J Cancer 124(12):2789\u20132796","journal-title":"Int J Cancer"},{"issue":"4","key":"9718_CR67","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.3390\/ijms14047742","volume":"14","author":"CE Pyragius","year":"2013","unstructured":"Pyragius CE et al (2013) Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer. Int J Mol Sci 14(4):7742\u20137756","journal-title":"Int J Mol Sci"},{"issue":"5\u20136","key":"9718_CR68","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000225157","volume":"33","author":"TK Basu","year":"1976","unstructured":"Basu TK, Dickerson JW (1976) The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. Oncology 33(5\u20136):250\u2013252","journal-title":"Oncology"},{"issue":"15","key":"9718_CR69","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1046\/j.1432-1327.2001.02329.x","volume":"268","author":"B Comin-Anduix","year":"2001","unstructured":"Comin-Anduix B et al (2001) The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem FEBS 268(15):4177\u20134182","journal-title":"Eur J Biochem FEBS"},{"issue":"11","key":"9718_CR70","first-page":"2671","volume":"30","author":"AM Pamukcu","year":"1970","unstructured":"Pamukcu AM et al (1970) Effects of the coadministration of thiamine on the incidence of urinary bladder carcinomas in rats fed bracken fern. Cancer Res 30(11):2671\u20132674","journal-title":"Cancer Res"},{"issue":"4","key":"9718_CR71","first-page":"169","volume":"10","author":"KV Lu\u2019o\u2019ng","year":"2013","unstructured":"Lu\u2019o\u2019ng KV, Nguyen LT (2013) The role of thiamine in cancer: possible genetic and cellular signaling mechanisms. Cancer Genomics Proteomics 10(4):169\u2013185","journal-title":"Cancer Genomics Proteomics"},{"issue":"2","key":"9718_CR72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/pr9008805","volume":"9","author":"H Zhang","year":"2010","unstructured":"Zhang H et al (2010) Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways. J Proteome Res 9(2):980\u2013989","journal-title":"J Proteome Res"},{"issue":"5","key":"9718_CR73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10585-010-9331-2","volume":"27","author":"CM Yang","year":"2010","unstructured":"Yang CM et al (2010) The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action. Clin Exp Metastasis 27(5):341\u2013349","journal-title":"Clin Exp Metastasis"},{"issue":"7155","key":"9718_CR74","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji H et al (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448(7155):807\u2013810","journal-title":"Nature"},{"key":"9718_CR75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2162-3619-2-18","volume":"2","author":"J Wang","year":"2013","unstructured":"Wang J et al (2013) Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Exp Hematol Oncol 2:18","journal-title":"Exp Hematol Oncol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-015-9718-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9718-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:37:26Z","timestamp":1566592646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-015-9718-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1007\/s10585-015-9718-1","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}